Advertisement

Topics

Amphora Discovery Corporation Company Profile

03:58 EDT 18th June 2018 | BioPortfolio

Amphora is a fully integrated drug discovery and development company. The company employs cutting-edge chemogenomic, systems biology and microfluidics technologies to develop innovative, targeted therapies for significant human diseases. Our primary mission is to improve patient care by rapidly developing proprietary human therapeutics that target the complex molecular causes of disease and to provide patients with treatment options that are more effective and better tolerated than currently available therapies. We strive to take drugs systematically from Database to IND in under two years. Amphora is committed to innovating first-in-class or best-in-class therapies for the treatment of cancer and other serious diseases where high unmet medical need exists.

Location

PO Box 12169Research Triangle Park
Research Triangle Park
North Carolina
27709-2169
United States of America

Contact

Phone: (919) 287 - 6200
Fax: (919) 806 - 3477


News Articles [387 Associated News Articles listed on BioPortfolio]

Evofem Biosciences Receives Fast Track Designation for Amphora for Prevention of Chlamydia

Amphora is an investigational drug being studied for the prevention of certain sexually transmitted infections (STIs) and as an on-demand, non-hormonal vaginal contraceptive. Fast Track Read more....

FDA Grants Evofem Biosciences’ Amphora Fast Track Designation

The U.S. Food and Drug Administration (FDA) granted San Diego-based Evofem Biosciences Fast Track designation for Amphora vaginal gel to prevent urogenital chlamydia infection in women.

FDA fast-tracks review of Evofem's women's chlamydia gel

Evofem Biosciences' Amphora, or L-lactic acid, citric acid and potassium bitartrate, vaginal gel, which is indicated to preve -More- 

Orion Corporation: Managers' transactions - Ari Lehtoranta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Ari Lehtoranta Orion Corporation has received the...

Orion Corporation: Managers' transactions - Liisa Hurme

ORION CORPORATION         MANAGERS' TRANSACTIONS 2nd of March 2018 at 9.45 EET Orion Corporation: Managers' transactions - Liisa Hurme Orion Corporation has received...

Orion Corporation: Managers' transactions - Timo Maasilta

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EETS Orion Corporation: Managers' transactions - Timo Maasilta Orion Corporation has received the ...

Orion Corporation: Managers' transactions - Eija Ronkainen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST Orion Corporation: Managers' transactions - Eija Ronkainen Orion Corporation has received...

Orion Corporation: Managers' transactions - Mikael Silvennoinen

ORION CORPORATION         MANAGERS' TRANSACTIONS 3 MAY 2018 at 11.40 EEST              Orion Corporation: Managers' transactions - Mikael Silvennoinen Orio...

PubMed Articles [499 Associated PubMed Articles listed on BioPortfolio]

The characterization and comparison of exopolysaccharides from two benthic diatoms with different biofilm formation abilities.

Exopolysaccharide (EPS) of two benthic diatoms, Amphora sp. and Stauroneis sp., with different biofilm formation abilities were investigated. The ratio of suspension-cells/biofilm-cells was employed t...

Translation of innovative chemistry into screening libraries: an exemplar partnership from the European Lead Factory.

The identification of high-quality starting points for drug discovery is an enduring challenge in medicinal chemistry. Yet, the chemical space explored in discovery programmes tends be limited by the ...

Protac-induced Protein Degradation in Drug Discovery: Breaking the Rules - or Just Making New Ones?

Targeted protein degradation, using bifunctional small molecules (Protacs) to remove specific proteins from within cells, has emerged as a novel drug discovery strategy with the potential to offer the...

Challenges with modelling anxiety disorders: a possible hindrance for drug discovery.

Challenges with biomarkers in cancer drug discovery and development.

Clinical Trials [170 Associated Clinical Trials listed on BioPortfolio]

Cystoscopic Ablation Via RF Energy Clinical Trial (CARET 2)

Two Phase Multicenter Study to Evaluate Safety and Efficacy of the Amphora OAB system for treatment of urgency and frequency with or without urge incontinence caused by an overactive bladd...

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Companies [1261 Associated Companies listed on BioPortfolio]

Amphora Discovery Corporation

Amphora is a fully integrated drug discovery and development company. The company employs cutting-edge chemogenomic, systems biology and microfluidics technologies to develop innovative, targeted the...

Queensfield International Inc

Amphora Aromatics Ltd supplies over 92 countries worldwide. So, with our ever growing popularity and with their permission, we are pleased to list some of our worldwide clients as official Amphora ret...

AMPHORA-RESEARCH

Computers are a critical part of R&D work, yet patent considerations mean most scientists have to document their research in a traditional bound paper lab notebook (BLN). This means a large amount of ...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Vyrex

VYREX CORPORATION, based in La Jolla, California, is a biopharmaceutical discovery and development company. Vyrex is engaged in research, discovery and development of innovative small molecule pharmac...

More Information about "Amphora Discovery Corporation" on BioPortfolio

We have published hundreds of Amphora Discovery Corporation news stories on BioPortfolio along with dozens of Amphora Discovery Corporation Clinical Trials and PubMed Articles about Amphora Discovery Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Amphora Discovery Corporation Companies in our database. You can also find out about relevant Amphora Discovery Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record